DexCom (NASDAQ:DXCM) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report released on Wednesday. Several other analysts also recently weighed in on the company. Canaccord Genuity Group lifted their target price on DexCom from $144.00 to $145.00 and gave the stock a buy rating in […]

Related Keywords

United States ,Canada ,Raymond James ,Michael Jon Brown ,Jeremem Sylvain ,Nasdaq ,Blair William Co ,Sands Capital Management ,Canaccord Genuity Group ,Citigroup ,Capital Research Global Investors ,Securities Exchange Commission ,Royal Bank ,Dexcom Inc ,Artisan Partners Limited Partnership ,Free Report ,Genuity Group ,Moderate Buy ,Get Free Report ,Exchange Commission ,Jon Brown ,Research Global Investors ,Capital Management ,World Investors ,Partners Limited Partnership ,Blair William ,Dexcom Share ,Dexcom Real Time ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Upgrade ,Stocknews Com ,